Literature DB >> 8981926

The human immunoglobulin V(H) gene repertoire is genetically controlled and unaltered by chronic autoimmune stimulation.

H Kohsaka1, D A Carson, L Z Rassenti, W E Ollier, P P Chen, T J Kipps, N Miyasaka.   

Abstract

The factors controlling immunoglobulin (Ig) gene repertoire formation are poorly understood. Studies on monozygotic twins have helped discern the contributions of genetic versus environmental factors on expressed traits. In the present experiments, we applied a novel anchored PCR-ELISA system to compare the heavy chain V gene (V(H)) subgroup repertoires of mu and gamma expressing B lymphocytes from ten pairs of adult monozygotic twins, including eight pairs who are concordant or discordant for rheumatoid arthritis. The results disclosed that the relative expression of each Ig V(H) gene subgroup is not precisely proportional to its relative genomic size. The monozygotic twins had more similar IgM V(H) gene repertoires than did unrelated subjects. Moreover, monozygotic twins who are discordant for RA also use highly similar IgM V(H) gene-subgroup repertoires. Finally, the V(H) gene repertoire remained stable over time. Collectively, these data reveal that genetic factors predominantly control V(H) gene repertoire formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981926      PMCID: PMC507745          DOI: 10.1172/JCI119106

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  A majority of Ig H chain cDNA of normal human adult blood lymphocytes resembles cDNA for fetal Ig and natural autoantibodies.

Authors:  C Huang; B D Stollar
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

2.  Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes.

Authors:  P N Akolkar; B Gulwani-Akolkar; R Pergolizzi; R D Bigler; J Silver
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

3.  Chromosomal organization of the human VH4 gene family. Location of individual gene segments.

Authors:  S van der Maarel; K W van Dijk; C M Alexander; E H Sasso; A Bull; E C Milner
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

4.  HAPPY mapping of a YAC reveals alternative haplotypes in the human immunoglobulin VH locus.

Authors:  G Walter; I M Tomlinson; G P Cook; G Winter; T H Rabbitts; P H Dear
Journal:  Nucleic Acids Res       Date:  1993-09-25       Impact factor: 16.971

5.  Influence of coding region polymorphism on the peripheral expression of a human TCR V beta gene.

Authors:  C S Vissinga; P Charmley; P Concannon
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

6.  A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q.

Authors:  G P Cook; I M Tomlinson; G Walter; H Riethman; N P Carter; L Buluwela; G Winter; T H Rabbitts
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

7.  A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles.

Authors:  E H Sasso; K Willems van Dijk; A P Bull; E C Milner
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

8.  Defining the genetic origins of three rheumatoid synovium-derived IgG rheumatoid factors.

Authors:  M Deftos; T Olee; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  The expressed T cell receptor V gene repertoire of rheumatoid arthritis monozygotic twins: rapid analysis by anchored polymerase chain reaction and enzyme-linked immunosorbent assay.

Authors:  H Kohsaka; A Taniguchi; P P Chen; W E Ollier; D A Carson
Journal:  Eur J Immunol       Date:  1993-08       Impact factor: 5.532

10.  "Homozygosity" for the HLA-DR shared epitope contributes the highest risk for rheumatoid arthritis concordance in identical twins.

Authors:  D Jawaheer; W Thomson; A J MacGregor; D Carthy; J Davidson; P A Dyer; A J Silman; W E Ollier
Journal:  Arthritis Rheum       Date:  1994-05
View more
  7 in total

1.  Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses.

Authors:  D H Margolin; K A Reimann; J Sodroski; G B Karlsson; K Tenner-Racz; P Racz; N L Letvin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation.

Authors:  S Munir Alam; Hua-Xin Liao; S Moses Dennison; Frederick Jaeger; Robert Parks; Kara Anasti; Andrew Foulger; Michele Donathan; Judith Lucas; Laurent Verkoczy; Nathan Nicely; Georgia D Tomaras; Garnett Kelsoe; Bing Chen; Thomas B Kepler; Barton F Haynes
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

3.  B-cell repertoire responses to varicella-zoster vaccination in human identical twins.

Authors:  Chen Wang; Yi Liu; Mary M Cavanagh; Sabine Le Saux; Qian Qi; Krishna M Roskin; Timothy J Looney; Ji-Yeun Lee; Vaishali Dixit; Cornelia L Dekker; Gary E Swan; Jörg J Goronzy; Scott D Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

4.  Two neutralizing human anti-RSV antibodies: cloning, expression, and characterization.

Authors:  C Heard; P Brams; E Walsh; T Huynh; S Chamat; M Reff; A Owyang; W Shestowsky; R Newman
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

5.  Differential use of immunoglobulin light chain genes and B lymphocyte expansion at sites of disease in rheumatoid arthritis (RA) compared with circulating B lymphocytes.

Authors:  S P Moyes; R N Maini; R A Mageed
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  Long-term kinetics of adult human antibody repertoires.

Authors:  Iris Van Dijk-Härd; Inger Lundkvist
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

7.  Molecular Insights of Nickel Binding to Therapeutic Antibodies as a Possible New Antibody Superantigen.

Authors:  Chinh Tran-To Su; Wai-Heng Lua; Jun-Jie Poh; Wei-Li Ling; Joshua Yi Yeo; Samuel Ken-En Gan
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.